Business
Tenon Medical, Inc. Announces Timing of Second Quarter 2023 Financial Results
LOS GATOS, CA / ACCESSWIRE / July 25, 2023 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering
About this update from Tenon Medical, Inc.
[{"type":"text","content":"LOS GATOS, CA / ACCESSWIRE / July 25, 2023 / Tenon Medical, Inc. (NASDAQ:TNON) (\"Tenon\" or the \"Company\"), a company transforming care for patients suffering with certain sacroiliac disorders, today announced plans to release financial results for the second quarter 2023 ended June 30, 2023 after market close on Tuesday, August 8, 2023. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call with conclude with a Q&A session with its covering analysts.Date:Tuesday, August 8, 2023Time:4:30 p.m. Eastern timeDial-in:1-800-830-9649International Dial-in:1-213-992-4624Webcast:TNON Conference CallPlease dial in at least 10 minutes before the start of the call to ensure timely participation.An audio playback of the call will be available through August 22, 2023, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921(USA) or 1-412-317-6671 (International). The access code will be 11152989.About Tenon Medical, Inc.Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran™ SI Joint Fusion System that offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI joint along its longitudinal axis. With an entry that mimics SI joint injection, the surgical approach is direct to the joint and inferior to the wide and variable dorsal recess. The angle and trajectory of the Inferior-Posterior approach is designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Tenon is preparing a national launch of this system to address the greatly underserved market opportunity that exists in this space. For more information, please visit www.tenonmed.com.The Tenon Medical logo and Tenon Medical, are registered trademarks of Tenon Medical, Inc. Catamaran is a trademark of Tenon Medical, Inc.Investor ContactShannon DevineMZ North [email protected]: Tenon Medical, Inc.View source version on accesswire.com: https://www.accesswire.com/769996/Tenon-Medical-Inc-Announces-Timing-of-Second-Quarter-2023-...